Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00566774 · ClinicalTrials.gov registry record · Phase 4
A Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies
A Phase 4 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 5,860
- Enrollment target
NCT00566774 is a Phase 4 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 5,860 participants.
The verdict
NCT00566774, a Phase 4 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 5,860 participants
- Enrollment target
Study Summary
The objective of this randomized trial is to evaluate the effect of providing full prescription drug coverage (i.e. no co-pays, co-insurance or deductibles) for statins, beta-blockers, angiotensin converting enzyme inhibitors and angiotensin II receptor blockers to patients recently discharged from hospital after acute myocardial infarction.
Interventions
- OTHER Full drug coverage
- OTHER Usual coverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,860 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00566774
The ClinicalTrials.gov registry entry for NCT00566774 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 5,860 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Full drug coverage is the first listed.
NCT00566774 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00566774 about?
NCT00566774 is a clinical study titled "A Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies". The objective of this randomized trial is to evaluate the effect of providing full prescription drug coverage (i.e. no co-pays, co-insurance or deductibles) for statins, beta-blockers, angiotensin converting enzyme inhibitors and angiotensin II receptor blockers to patients recently discharged from ...
What is the current status of trial NCT00566774?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 5,860 participants. The study started on 2007-11. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00566774?
The interventions under investigation include: Full drug coverage (OTHER), Usual coverage (OTHER).
Who is sponsoring clinical trial NCT00566774?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.